U.S. flag

An official website of the United States government

NM_000077.5(CDKN2A):c.151G>A (p.Val51Ile) AND not specified

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jul 31, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001193450.2

Allele description [Variation Report for NM_000077.5(CDKN2A):c.151G>A (p.Val51Ile)]

NM_000077.5(CDKN2A):c.151G>A (p.Val51Ile)

Gene:
CDKN2A:cyclin dependent kinase inhibitor 2A [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
9p21.3
Genomic location:
Preferred name:
NM_000077.5(CDKN2A):c.151G>A (p.Val51Ile)
HGVS:
  • NC_000009.12:g.21971208C>T
  • NG_007485.1:g.28284G>A
  • NM_000077.5:c.151G>AMANE SELECT
  • NM_001195132.2:c.151G>A
  • NM_001363763.2:c.-3G>A
  • NM_058195.4:c.194G>A
  • NM_058197.5:c.*74G>A
  • NP_000068.1:p.Val51Ile
  • NP_000068.1:p.Val51Ile
  • NP_001182061.1:p.Val51Ile
  • NP_478102.2:p.Gly65Asp
  • LRG_11t1:c.151G>A
  • LRG_11:g.28284G>A
  • LRG_11p1:p.Val51Ile
  • NC_000009.11:g.21971207C>T
  • NM_000077.4:c.151G>A
Protein change:
G65D
Links:
dbSNP: rs762630679
NCBI 1000 Genomes Browser:
rs762630679
Molecular consequence:
  • NM_058197.5:c.*74G>A - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001363763.2:c.-3G>A - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000077.5:c.151G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001195132.2:c.151G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_058195.4:c.194G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001362281Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 27, 2019)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link,

SCV005090826Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jul 31, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Recurrent patterns of dual RB and p53 pathway inactivation in melanoma.

Yang G, Rajadurai A, Tsao H.

J Invest Dermatol. 2005 Dec;125(6):1242-51.

PubMed [citation]
PMID:
16354195

Targeted molecular profiling of rare genetic alterations in colorectal cancer using next-generation sequencing.

Jauhri M, Bhatnagar A, Gupta S, Shokeen Y, Minhas S, Aggarwal S.

Med Oncol. 2016 Oct;33(10):106. doi: 10.1007/s12032-016-0820-2. Epub 2016 Aug 27.

PubMed [citation]
PMID:
27568332
See all PubMed Citations (5)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001362281.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

Variant summary: The CDKN2A gene encodes multiple alternative transcripts, coding for different proteins; the most well-studied are the p16 (INK4A) and the p14 (ARF) proteins. In p16 (INK4A) the variant results in c.151G>A (p.Val51Ile), causing a conservative amino acid change located in the Ankyrin repeat-containing domain with four of five in-silico tools predict a damaging effect of the variant on protein function. Alternatively, in p14 (ARF) this nucleotide change results in the formation of c.194G>A (p.Gly65Asp). An in silico study predicted that the variant has a benign effect for p16 and is possibly damaging for ARF (Yang 2005). In addition, this variant is located at the first 5' position in exon 2: 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 4.5e-06 in 220322 control chromosomes (gnomAD). The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.151G>A has been reported in the literature as a somatic variant in various tumors (e.g. Ohta 1996, COSMIC database, Jauhri_2016). However, these report(s) do not provide unequivocal conclusions about association of the germline variant with Cutaneous Malignant Melanoma. At least one publication reports experimental evidence evaluating an impact on protein function, demonstrating that the variant had no damaging effect on the mouse homologue of the p16 protein (i.e. it had similar function to the WT), however, authors did not test the effect of the variant on the other affected protein, p19 ARF (the mouse homologue of p14 ARF) (Zhang 2001). Therefore these data do not allow convincing conclusions about the variant effect. A ClinVar submission from a clinical diagnostic laboratory (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV005090826.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024